Document is current
Any future updates will be listed below
-
Authors
Li, Tao
Guo, Chuan
Liu, Qing
Jing, Fengting
Zhao, Min
Xiong, Hemin
Li, Chang
Zhang, Wei
Chen, Bo
-
Funding
Funding for this research was provided by:
the National Natural Science Foundation of China (31900813)
Sichuan Provincial Science and Technology Support Program (2025ZNSFSC0710, 2022YFS0627)
Southwest Medical University Science and Technology Project (2023QN096)
- License Information
-
More Information
Article History
Received: 26 May 2025
Accepted: 24 September 2025
First Online: 28 October 2025
Declarations
:
: This study was approved by the Ethical Committee of Southwest Medical University. All procedures involving animals were conducted in accordance with the guidelines set forth by the Southwest Medical University for the care and use of laboratory animals. (1) Title of the approved project : The Molecular Mechanism of Bone Marrow-Derived MSCs Against Renal Fibrosis; (2) Name of the institutional approval committee or unit: Southwest Medical University Experimental Animal Center; (3) Approval number: SWMU20240014; (4) Date of approval: Nov 20, 2023.
: All authors agree to publish this article.
: The authors declare no competing interests.
